CareDx Shares Rise Over 9% After Guidance Increase
Shares of CareDx (CDNA) climbed more than 9% on Monday following the company's raised full-year revenue guidance and strong second-quarter results. This continued a previous session’s surge, where shares had already risen by about 15%. The stock reached a new 52-week high as investors reacted positively to improved financial outlooks from CareDx. CareDx is a precision medicine diagnostics company focused on transplant patients. Its recent performance has been driven by better-than-expected results and an upward revision of its annual revenue forecast, signaling confidence in the business's growth trajectory.
Tickers: $CDNA
Topics: caredx cdna precision medicine stock movement transplant diagnostics